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Abstract
Background: The potential of technology to aid integration of care delivery systems is being explored in a range of contexts
across a variety of conditions in the United Kingdom. Prostate cancer is the most common cancer in UK men. With a 10-year
survival rate of 84%, there is a need to explore innovative methods of care that are integrated between primary health care providers
and specialist teams in order to address long-term consequences of the disease and its treatment as well as to provide continued
monitoring for recurrence.
Objective: Our aim was to test the feasibility of a randomized controlled trial to compare a model of prostate cancer continuing
and follow-up care integration, underpinned by digital technology, with usual care in terms of clinical and cost-effectiveness,
patient-reported outcomes, and experience.
Methods: A first phase of the study has included development of an online adaptive prostate specific Holistic Needs Assessment
system (HNA), training for primary care-based nurses, training of an IT peer supporter, and interviews with health care professionals
and men with prostate cancer to explore views of their care, experience of technology, and views of the proposed intervention.
In Phase 2, men in the intervention arm will complete the HNA at home to help identify and articulate concerns and share them
with their health care professionals, in both primary and specialist care. Participants in the control arm will receive usual care.
Outcomes including quality of life and well-being, prostate-specific concerns, and patient enablement will be measured 3 times
over a 9-month period.
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Results: Findings from phase 1 indicated strong support for the intervention among men, including those who had had little
experience of digital technology. Men expressed a range of views on ways that the online system might be used within a clinical
pathway. Health care professionals gave valuable feedback on how the output of the assessment might be presented to encourage
engagement and uptake by clinical teams. Recruitment to the second phase of the study, the feasibility trial, commenced March
2017.
Conclusions: To our knowledge, this study is the first in the United Kingdom to trial an online holistic needs assessment for
men with prostate cancer, with data shared between patients and primary and secondary care providers. This study addresses
recommendations in recent policy documents promoting the importance of data sharing and enhanced communication between
care providers as a basis for care integration. We anticipate that this model of care will ultimately provide important benefits for
both patients and the National Health Service.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 31380482;
http://www.isrctn.com/ISRCTN31380482 (Archived by WebCite at http://www.webcitation.org/6s8I42u5N)
(JMIR Res Protoc 2017;6(7):e147)  doi: 10.2196/resprot.7667
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Introduction
Increasing numbers of cancer patients and cancer survivors
represent a growing demand on overstretched specialist
secondary care services in the United Kingdom. Evidence
indicates that these services often fail to meet the various needs
of survivors [1-4]. The potential role for primary care in
addressing these needs and reducing the demand on specialist
services is now widely recognized [5]. In response, there has
been a rapid increase in recent years in interventions aiming to
introduce and evaluate integrated and shared approaches to care,
in which primary care services take on an extended role in the
care of patients during or following treatment [6,7]. Macmillan
Cancer Support has promoted greater primary care involvement
with patients with cancer and has developed and rolled out a
training program in cancer follow-up for practice nurses [8].
Prostate cancer is the most common cancer in men, with over
47,000 men diagnosed each year in the United Kingdom [9].
With current 10-year survival rates of 84% [10], there are over
330,000 men in the United Kingdom living with and after
prostate cancer. Men with prostate cancer follow a range of
treatment pathways depending on factors such as the stage their
cancer was diagnosed, comorbidities, and patient choice. They
often live with the direct consequences of their illness or
treatment, such as urinary, sexual and bowel problems, as well
as fatigue. These symptoms can have a negative impact on
men’s quality of life [11-14]. Men on hormone treatment also
face an increased risk of osteoporosis and cardiovascular events
[15-18]. In addition, men are often affected by indirect
consequences of their cancer such as social, financial, and
psychological difficulties [4,19,20]. In particular, men may
suffer from anxiety and depression, both during initial treatment
and thereafter [21,22]. These may be especially pronounced if
they have a lack of positive support, detrimental interactions,
and a high perceived threat of cancer [23]. This may contribute
to men with prostate cancer reporting a worse experience of
care and follow-up than those with other cancers [24,25]. There
is also evidence that problems may remain unrecognized and
unaddressed and may persist for many years [26-28].
While high survival rates in prostate cancer are extremely
encouraging, there remains a need for greater attention to quality
of life. As well as treatment of the disease and its physical
symptoms, methods to identify men’s emotional and
psychological concerns, or “holistic needs,” are required. Care
pathways that are designed to address these from an early stage
are needed.
A Role for Primary Care
While protocols vary widely throughout the United Kingdom,
the National Institute for Health and Care Excellence (NICE)
has recommended that after 2 years of secondary care based
follow-up, care should be transferred to the general practitioner
(GP) as long as there are no concerning symptoms or treatment
complications [29]. Many specialist services currently transfer
care of men with “stable” disease either after surgery or on
hormone treatment to primary care providers under locally
enhanced or incentivized service arrangements with provision
for men to return to specialist care if necessary. Primary care
clinicians appear willing to undertake an early role in follow-up
[30-32]. Interventions that increase communication between
primary and secondary specialist services have been shown to
facilitate the transfer of care process [33].
Practice nurses and other primary care team members are well
placed to understand the wide ranging needs of men with
prostate cancer with their knowledge of each patient’s
comorbidities, family, and social circumstances. They are also
better placed to provide opportunistic support, as GP
consultation rates for men with prostate cancer are around three
times higher than those of their peers [34]. Much of their
expertise and skills in the care of patients with chronic
conditions in relation to supporting self-management may be
transferable to prostate cancer care. Primary care staff may also
have detailed knowledge of local resources that may be of value
to the patient, and GPs may make direct referrals to community
support services. Evaluation within one Clinical Commissioning
Group, where follow-up for stable patients has been transferred
to primary care, has demonstrated benefits in terms of patient
experience and costs and barriers to the pathway redesign
JMIR Res Protoc 2017 | vol. 6 | iss. 7 | e147 | p. 2http://www.researchprotocols.org/2017/7/e147/
(page number not for citation purposes)
Nanton et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
including issues around primary and secondary care
communication [35].
Holistic Needs Assessment
In recognition of the changing needs of cancer patients
throughout their cancer journey, “holistic needs assessment” as
a method of identifying, assessing, and planning appropriate
care has been widely promoted for use in the specialist
secondary care setting. The National Cancer Survivorship
Initiative’s “Living with and beyond cancer programme”
recommended that all cancer patients should have access to a
Holistic Needs Assessment (HNA) and Care Plan [36]. The
program promotes the use of the HNA for encouraging patients
to self-manage during and after their treatment. A recent
National Prostate Cancer Audit [37] has also highlighted the
importance of identifying the needs of men with prostate cancer
and linking men to appropriate services. While there is general
agreement regarding the potential of the HNA, there is little
evidence of effectiveness [38,39]. Adoption of the HNA with
respect to men with prostate cancer has also been shown to be
uneven, with staff identifying barriers including the time needed
for completion in clinic (Prostate Cancer UK unpublished
report). To address the limitations of a paper-based system [40],
Macmillan Cancer Support has developed an electronic generic
HNA. Evaluation has demonstrated acceptability of the
electronic format to both patients and staff but pointed out
difficulties of implementation within the secondary care setting
[41]. To date, there is little indication of uptake of such
assessments tools within general practice.
Information Technology
The use of information technology (IT) in cancer patient
follow-up and primary care has been explored in the United
States [42], Norway [43,44], and Australia [45] but has as yet
received limited attention within the United Kingdom. However,
technology now well embedded within general practice
management is increasingly incorporated into patient care in a
variety of forms and across a range of conditions (eg [6,46-50]).
The GP Forward View policy document describing the National
Health Service (NHS) plans for developing general practice in
the next 5 years emphasizes its increasing importance and
includes a key policy aim to support the design and adoption
of technology that enables patient self-care and
self-management. The document also highlights the central role
of technology in improving primary and secondary care
communication and the provision of integrated care [51].
Secondary care adoption of IT, however, has been comparatively
slow and the need for secondary care digitization, including
patient-facing systems, has recently been highlighted by the
National Advisory Group on Health Information Technology
in England [52].
In order to better address the ongoing needs of men with prostate
cancer and to try to reduce the pressures on specialist services,
we have designed an innovative study that brings together IT,
HNA, and primary care involvement throughout the cancer
pathway. Our intervention aims to promote an integrated
approach to care through enhanced communication between the
patient and health care providers. This protocol describes a
feasibility study in which an online prostate-specific HNA is
shared between patient and their clinical teams. In addition, our
study involves training for practice nurses in collaboration with
Macmillan Cancer Support and ongoing support from specialist
teams. To our knowledge, this is the first UK-based study in
which IT provides the basis for a primary care based intervention
in prostate cancer and the first UK-based study that seeks to
develop an integrated and holistic approach to care for all men
with prostate cancer from diagnosis onwards.
Methods
Design
This study involves a complex intervention [53] that includes
both the development of patient self-efficacy and the
implementation of organizational change [54]. Hence, we have
adopted a mixed-methods, two-phase design. Phase 1 of the
study (March-November 2016) was designed to include
technical development, training, recruitment, and qualitative
interviews. Phase 2 is a nonrandomized cluster controlled trial
of the intervention. Follow-up interviews will be undertaken
with patient participants and health professionals to explore
their experience of the trial.
Population, Setting, and Inclusion Criteria
Our study population extends to all men who have ever had a
diagnosis of prostate cancer. The selection of this population
offers the opportunity for participation to any man who may
have problems related to prostate cancer, whether currently
receiving treatment, monitoring, or follow-up. This will allow
us to identify the wide range of short- and long-term concerns
that may occur during or following different treatment regimens.
The study is set in 14 general practices including 10 intervention
and 4 control practices within one Clinical Commissioning
Group (CCG) in the West Midlands and one specialist secondary
care site within an NHS Foundation Trust hospital. Eligibility
for general practices is determined by location within the
participating CCG and a referral pathway to the specialist center.
Practices must also be willing to support a practice nurse taking
part in the Macmillan training program and the prostate specific
training or to enable a primary care research nurse who has
undergone the training to run the study within the practice.
Patient eligibility for each of the study phases requires
registration with any of the participating practices and diagnosis
of prostate cancer or treatment at any time at the participating
specialist center. Men must be able to read written and
understand spoken English and be able and willing to give
informed consent. GPs’ screening of the list of potentially
eligible men ensures capacity to participate.
Men are ineligible for inclusion if they are aged under 18 years,
unable to give informed consent, unable to complete outcome
measures, living in a care setting, suffer from mental health
problems, or are unable to communicate in English.
Practice nurses and GPs from participating practices are eligible
to take part in interviews prior to or following the intervention.
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Phase 1 Summary
During Phase 1, the HNA has been finalized and installed on a
secure study website at the participating Trust. Participating
patients, associated clinicians in secondary and primary care,
and members of the study team have access to the site. Ten
intervention and 4 control general practices within the
participating CCG have been recruited. Five Macmillan trained
nurses recruited to the study have undertaken additional prostate
cancer training at the specialist secondary care center. One
volunteer peer supporter has been recruited and trained in order
to help men complete the HNA if needed. Qualitative
semistructured interviews have been undertaken with 8 primary
care based health care professionals and 10 patient participants
recruited through their general practices. The purpose of the
interviews was to determine variation in delivery and experience
of usual care and to identify barriers and facilitators to
implementation of the intervention and to assess the views of
health care professionals and patients on the online HNA.
Findings from Phase 1 demonstrate an enthusiasm for the project
among patients. Men who have had little experience with IT
have expressed a willingness to take part, in some cases despite
a lack of access to the Internet. We have responded to this
potential barrier by equipping the ITmate peer supporter with
an Internet-enabled tablet computer. Health professionals have
also been supportive of the study and acknowledged the potential
of the intervention. GPs in particular expressed the importance
of a brief output from the HNA, hence the summary document
generated by the assessment has been designed to be concise
and easily interpreted.
Aims and Objectives
The aim of the trial is to test the feasibility of undertaking a
future cluster randomized controlled trial (RCT) comparing a
model of integrated prostate cancer continuing care and
follow-up care with usual care in terms of clinical and
cost-effectiveness, patient-reported outcomes, and experience.
Trial objectives are to (1) assess the fidelity of intervention
delivery, and the acceptability and utility of the intervention by
patients and primary and secondary care clinicians, (2) test
patient recruitment, data collection, and retention in both
intervention and control practices, (3) analyze how the HNA is
used by men over a 9-month period, with self-assessment
completed at baseline, 3 months, and 6 months, (4) test the
willingness of clinicians and patients to provide qualitative and
quantitative data including process data and measurement of
outcomes, (5) test the feasibility of collecting use of resource
data and process data, including numbers of primary and
specialist contacts and consultations, (6) identify the most
suitable primary outcome measure and refine secondary outcome
measures for a future cluster RCT, and (7) estimate parameters
for a sample size calculation for cluster RCT.
The Holistic Needs Assessment Instrument
The HNA is an online self-assessment tool designed to capture
the needs of men who have had a diagnosis of prostate cancer.
It is composed of 11 different sections, including Physical
Health, Emotional and Psychological Issues, Independence and
Activity, and Access to Services. These can be used flexibly so
that men can complete all of the sections or only the ones they
feel are relevant to them, in any order, and in their own time.
As men work through the assessment, they are shown links to
advice pages or videos on websites such as Prostate Cancer UK,
with the aim of encouraging and enabling self-management.
This system shows a “red flag” if a patient reports having any
physical or psychological symptoms of serious concern, for
example, “blood in urine” or “thoughts of ending it all” with a
prompt to visit their GP as soon as possible. The system will
also alert the clinician to these red flags when they access the
output from their patient’s HNA. At the end of each section,
men have the facility to disclose additional concerns, and this
text is inserted into the summary generated on completion of
the assessment. This summary auto-populates the first pages of
a Care Plan to be completed with a health professional.
The system has been designed to be attractive and easy to
navigate. Figures 1 and 2 illustrate two of the initial screens.
The online HNA has been finalized following an iterative
process of user and patient testing (Prostate Cancer UK
unpublished report). It has been installed on a study website
hosted on a Trust server and penetration tested to ensure
security.
The project platform incorporates three elements: (1) a Web
app for patients to complete the holistic needs assessments, (2)
a Web app for nurses to review those assessments and record
care plans, and (3) a windows app design to allow administration
of the project such as adding patient or nurse users and
monitoring completion of study stages by the research team.
Intervention
Participants in the intervention group will be invited to complete
the HNA three times in a 9-month period. Following submission
of the assessment, men will be invited to make an appointment
with the nurse to discuss any concerns identified and to complete
and personalize the care plan. The care plan will summarize
any topics discussed, outcomes or referrals, actions taken
regarding any “red flag” symptoms, and actions to be undertaken
by the man himself. The document will be generated and a copy
given to participants and added to their patient notes. Where
specific clinical concerns are identified, sharing of the online
data with the secondary care team will enable rapid specialist
advice or referral. If the participants attend the surgery between
the three study appointments, practice nurses or GPs will be
encouraged to undertake opportunistic reinforcement of the care
plan, for example, checking whether the man has undertaken
any actions he has agreed to in the plan or whether referrals
made have led to appointments.
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Figure 1. The HNA login screen.
Figure 2. Assessment page showing the different sections of the HNA.
If the participant is a patient undergoing ongoing treatment at
the specialist center, study participation will be flagged in his
notes. Relevant secondary care clinicians will be able to access
the participants assessment summary and care plan prior to or
during an appointment. If any concerns other than clinical issues
related to the prostate cancer arise in the consultation (eg,
occupational or family concerns, worries over comorbidities),
the secondary care clinician may, with the participant’s
permission, contact the primary care based nurse.
Usual Care
Usual care comprises a community-based, stable prostate clinical
care pathway. Men with advanced disease on hormone treatment
are also largely seen in primary care for their injections and will
be seen only in secondary care if their prostate specific antigen
(PSA) rises above a threshold or other complications occur.
Care of men by specialist teams continues up until 3 years
postcurative treatment and is reintroduced if a clinical need
arises (symptoms that are suggestive of prostate cancer
progression, eg, significant rise in PSA, suspected metastases,
pain or treatment complication, deteriorating renal function).
Men on active surveillance are excluded from this pathway.
Men who do not meet the criteria continue to be seen by
secondary care teams.
Recruitment
The GP and practice nurse will search for eligible patients, who
will then be sent a participant information sheet and a covering
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letter of invitation to participate signed by the GP. If patients
are considering taking part in the study or have decided to do
so, they will return an enclosed reply slip to the study team. If
there has been no response after 2 weeks from the initial contact,
the practice nurse will telephone to check whether the patient
is interested. Patients can also be invited to take part on an
opportunistic basis, such as during a routine appointment.
Written consent will be taken by a member of the study team.
Data Collection
Participants in the intervention group will complete the HNA
at baseline, as well as 3 months and 6 months later. We will use
six validated questionnaires to measure unmet need, quality of
life, and general health and well-being of participants: the
Cancer Survivors Unmet Needs instrument [55], the Patient
Activation Measure [56], the Expanded Prostate Cancer Index
Composite [57], the EuroQol five dimensions questionnaire
(EQ5D) [58], the European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire
(EORTC-QLQ) [59], and the Warwick and Edinburgh Mental
Well-being Scale [60], as participants in the intervention group
progress through the study. At baseline and 9 months later,
participants in both the intervention and control groups will
complete all the outcome measures. Participants in the
intervention group will also complete a smaller subset of
outcome measures before consultations at 3 and 6 months. Men
can either complete these online or fill out paper copies for
postal return.
A small number of patients from the intervention group (n<10)
will be followed up at the end of the study for an interview
about their experiences of the intervention. We will also invite
participants to complete an HNA technology acceptance and
usability questionnaire developed by members of the study
team.
Outcomes
Patient and feasibility outcomes will be assessed. In order to
determine feasibility of carrying out a larger scale RCT to
compare the intervention with usual care, we will evaluate this
study in terms of >25% eligible men consenting to participate
in the study and >70% of participants in the intervention group
completing the HNA and the patient outcome measures at each
time point.
Figure 3 illustrates the study pathway.
Analysis
Quantitative
The analyses will be exploratory and mainly descriptive. Point
estimates and corresponding 90% confidence intervals will be
calculated for all outcome measures in both arms, and their
distributions will be assessed to identify appropriate statistical
analysis methods for a future RCT. Hierarchical mixed models
accounting for within GP practice correlation will be fitted for
potential primary outcomes to explore the effect of the
intervention relative to usual care at a single time point as well
as over time (repeated measures model). Propensity score
matching and regression adjustment techniques will be used as
sensitivity analyses and to minimize potential bias in outcomes
estimates due to the nonrandomized nature of the study.
Data will be downloaded from the HNA database to assess
completion rates at each time period, sequential completion
over a year, and analysis of the needs identified.
Qualitative
Thematic analysis of the interviews will also take place with
the audiorecorded data transcribed and entered into a software
analysis package (NVivo 10). Members of the research team
will each identify broad themes from close reading of the
interview transcripts. Further themes and subthemes will be
developed through an iterative process of coding, categorization,
and discussion between team members. Topics to be explored
include men’s experiences of the new model of care, advantages
and disadvantages of the intervention, and any impact on heath
and confidence in self-management.
Health Economic Analysis
Completion rates for collecting resource utilization data, contacts
with health care professionals and referrals to hospitals and
other community health and social care providers will be
evaluated. Data collected at each time point will be analyzed to
provide preliminary indications of the costs associated with the
intervention over the 9-month period.
Intervention Fidelity
Researchers within the project team are able to access the
ICARE-P admin site. This will allow the tracking of completion
of HNAs and Care Plans and to identify how the software has
been used by participants and health professionals. Content of
the HNAs and Care Plans are also accessible to these members
of the research team. Analysis of Care Plans and referral data
retrieved from practices will allow assessment of intervention
fidelity.
Ethics
Phase 1 of the study was approved by NHS Research Ethics
Committee proportionate review process (ref: 15/EM/0534).
Phase 2 was considered and approved under full review (ref:
16/YH/0278).
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Figure 3. Flowchart for ICARE-P Adapted from CONSORT guidelines for randomized controlled trials.
Discussion
Principal Considerations
The online HNA that forms the cornerstone of our intervention
puts the patient at the center of care [61], enabling him to
identify and express concerns to both primary care and specialist
teams, as well as encouraging and facilitating self-management.
The adaptive nature of the HNA ensures its suitability for men
from early diagnosis onwards regardless of treatment modality
or their stage in the care pathway. The online system offers an
opportunity for integrated care allowing all linked clinicians
access to the HNA output in which prostate specific clinical
issues, broader concerns, or issues related to comorbidities are
summarized.
Integration between primary and specialist secondary care
services and the role of technology in supporting this aim
represent key themes of the five-year forward policy document
[51]. Integrated services offer advantages to patients in terms
of continuity and coordination together with a potential for
streamlining of provision. Interoperability of systems that allow
easy data sharing are critical to integration, and the
implementation of such systems has been identified as priority
in a recent report by the National Advisory Group on Health
Information Technology in England [52]. Primary care clinicians
interviewed in Phase 1 of our study endorsed the need for
improvements in communication with specialist colleagues,
expressing frustration at the speed of current systems. The report
has also highlighted the relatively slow adoption of digital
technology in secondary care compared with high levels of
primary care digitization and has emphasized the need for
secondary care implementation. Barriers identified include
extreme caution in relation to data security and a lack of
attention to the needs of the end user when systems have been
developed and put in place. Our HNA and Care Plan have been
designed for ease of use by patients and clinicians, and they
aim to be comprehensive yet relevant. We have provided
training for participating clinicians in the use of the system to
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encourage engagement with the study. To overcome any
difficulties patients may experience, we have the trained ITmate
available to assist them. We have met the need to conform to
rigorous data security standards and have worked collaboratively
with our participating NHS Trust, our institution, and our IT
partners to ensure all requirements are met.
A further recommendation of the report is a stepwise approach
to digitization. We recognize the importance of such an approach
both from the technological and the behavioral standpoints.
This study introduces an innovative approach to the care of men
with prostate cancer; however, more can be achieved.
If feasibility aims are met in terms of recruitment (>25% of
eligible men and >70% retention) and usability and acceptability
testing with patients and clinical teams indicate support for the
intervention, further technical development of the HNA is
proposed prior to a full effectiveness trial. This development
will involve full integration of the HNA within the Trusts’ own
clinical data management system and the development of an
enhanced communication pathway between specialist and
primary care teams enabling automated alerts and notifications.
Limitations
As a feasibility study, the sample size involved is limited. A
nonrandomized controlled trial may result in some biases (in
particular confounding and allocation bias). We aim to reduce
these biases through the use of regression adjustment and
propensity score matching.
Conclusion
This study is the first of its kind to trial an online HNA for men
with prostate cancer with data shared between patients and
primary and secondary care providers. We anticipate that this
system will ultimately provide important benefits for patients
in terms of addressing unmet needs, identifying concerning
symptoms, and enabling self-management, and benefits to the
NHS in terms of effective use of resources and appropriate use
of skills.
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